With the high burden of metabolic disease increasing in the US, Sophia Humphreys, PharmD, Sutter Health, explains how this impacts health equity.
Amid the increasing burden of diabetes and heart failure in the US, Sophia Humphreys, PharmD, MHA, BCBBS, Sutter Health, explained how this impacts the equity of health care in an interview before her presentation at The American Journal of Managed Care® (AJMC®) Institute for Value-Based Medicine® event hosted by Sutter Health in San Francisco, California.
As the director of Formulary Management and Clinical Services, Humphreys’ “passion is to bring the highest quality medication to our patients with the lowest cost for our society.”
Transcript
Your presentation began with the increasing burden of diabetes and heart failure. What does this rapidly growing burden mean for the future of treatment and care?
That's a very good question. As you know, our population is aging; as our population ages, in the meantime, we're seeing obesity become more and more prevalent. With obesity, we see higher risk and higher incidence of diabetes. That's why we see the growing epidemiology of diabetes. As you know, diabetes is a higher risk factor for both stroke and cardiovascular issues. And we are seeing a high burden both on our patients as well as our health care system.
Sutter [Health] is a nonprofit health system. We see a diverse population here in Northern California. So it is our passion to provide the best quality care to improve our population health and improve patients’ quality of life and, in the meantime, maintain affordability for all.
Can you elaborate on the health equity concerns you highlighted related to heart failure?
In the beginning, when we studied heart failure treatment, really, health equity was not a primary focus. However, recent studies have revealed that we are seeing the different marginalized socioeconomic groups and the different racial groups have higher risk as well as lower clinical outcomes, even if they have similar access to care. So health equity is becoming more and more important to our health care leaders, as well as our entire industry as scientists focus. So, in Northern California, we have a diverse population, we have a very high percentage of African Americans, we have a very high percentage of Hispanic population, as well as Asian and Pacific Islanders. So, we really wanted to make sure that all of our patients across racial, across socioeconomic backgrounds, across payer mix, all receive the highest quality of care, within Sutter and without Sutter and within the entire region.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
The Senate Finance Committee has introduced bipartisan legislation that proposes using Medicaid and Medicare programs to help prevent and reduce generic drug shortages; US indicators for COVID-19, flu, and respiratory syncytial virus (RSV) declined further last week; findings from a recent study reveal growing disparities in child death rates across racial and ethnic groups.
Read More